Cerus Corporation (CERS) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.
Over the past 4 years, Cerus Corporation has achieved a revenue compound annual growth rate (CAGR) of 15.2%, while earnings have grown at -23.1% CAGR.
Historical revenue and profitability trends for Cerus Corporation
The chart above illustrates Cerus Corporation's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Cerus Corporation's business.
How efficiently Cerus Corporation converts revenue into profit
Profit margins reveal how much of each dollar of revenue Cerus Corporation retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Cerus Corporation to continue growing earnings in the coming year. The consensus analyst rating is 4.6 based on 5 analysts.
Based on our comprehensive analysis, Cerus Corporation (CERS) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Cerus Corporation's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Cerus Corporation stacks up against similar companies
Explore growth analysis for top stocks
Related: CERS Valuation, CERS Dividend, CERS Financial Health
Compare: CERS vs AAPL, CERS vs MSFT, CERS vs GOOGL